The aldosterone-to-renin ratio test measures the levels of aldosterone and renin in the blood and calculates the ratio between the two. It is used to diagnose conditions like primary aldosteronism, where excess aldosterone production leads to high blood pressure and low potassium levels. A high ratio may indicate this condition, and treatment options include medications or surgery. Healthcare providers interpret the results alongside other clinical findings and tests.
The aldosterone-to-renin ratio (ARR) test evaluates the balance between aldosterone and renin in the body. It helps diagnose primary hyperaldosteronism by comparing levels of these hormones, indicating adrenal gland issues. The test involves measuring hormone levels from a blood sample to calculate the ARR. It is an initial step, requiring further testing for a confirmed diagnosis, and medical evaluation is recommended if primary hyperaldosteronism is suspected.
Microalbuminuria is a condition characterized by elevated albumin levels in urine, indicating kidney damage, often linked to diabetes, hypertension, or certain medications. Monitoring microalbumin levels can aid in early detection and management of kidney disease, with treatment typically involving lifestyle adjustments, medication, and regular kidney function monitoring.
The Trans-Hormone Wellness Panel is a comprehensive blood test designed for individuals who are transitioning from male to female. This panel measures the levels of estrogen and testosterone hormones in the blood, providing valuable information for healthcare providers to monitor and adjust hormone replacement therapy (HRT). The test includes measurements of estradiol, estrone, and estradiol valerate, as well as testosterone and dihydrotestosterone (DHT), to assess the effectiveness of HRT and identify potential imbalances. This panel is essential for transgender women seeking to achieve and maintain optimal hormone balance during their transition.